People / Staff

Jaume Mora Graupera

Search publications

Publications

  • Duhme C, Busch M, Heine E, de Torres C, Mora J and Royer-Pokora B.

    WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 43(2): 180-183. Number of citations: 5

    [doi:10.1097/MPH.0000000000001697]

  • Aschero MR, Francis JH, Ganiewich D, Gomez-Gonzalez S, Sampor C, Zugbi S, Ottaviani D, Lemelle L, Mena M, Winter U, Correa Llano G, Lamas G, Lubieniecki F, Szijan I, Mora J, Podhajcer O, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lavarino C and Chantada G.

    Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma

    Cancers . 13(4): 673. Number of citations: 16

    [doi:10.3390/cancers13040673]

  • Koelsche C, Schrimpf D, Stichel D, Sill M, Sahm F, Reuss DE, Blattner M, Worst B, Heilig CE, Beck K, Horak P, Kreutzfeldt S, Paff E, Stark S, Johann P, Selt F, Ecker J, Sturm D, Pajtler KW, Reinhardt A, Wefers AK, Sievers P, Ebrahimi A, Suwala A, Fernández-Klett F, Casalini B, Korshunov A, Hovestadt V, Kommoss FKF, Kriegsmann M, Schick M, Bewerunge-Hudler M, Milde T, Witt O, Kulozik AE, Kool M, Romero-Pérez L, Grünewald TGP, Kirchner T, Wick W, Platten M, Unterberg A, Uhl M, Abdollahi A, Debus J, Lehner B, Thomas C, Hasselblatt M, Paulus W, Hartmann C, Staszewski O, Prinz M, Hench J, Frank S, Versleijen-Jonkers YMH, Weidema ME, Mentzel T, Griewank K, de Álava E, Martín JD, Gastearena MAI, Chang KT, Low SYY, Cuevas-Bourdier A, Mittelbronn M, Mynarek M, Rutkowski S, Schüller U, Mautner VF, Schittenhelm J, Serrano J, Snuderl M, Büttner R, Klingebiel T, Buslei R, Gessler M, Wesseling P, Dinjens WNM, Brandner S, Jaunmuktane Z, Lyskjær I, Schirmacher P, Stenzinger A, Brors B, Glimm H, Heining C, Tirado OM, Sáinz-Jaspeado M, Mora J, Alonso J, Del Muro XG, Moran S, Esteller M, Benhamida JK, Ladanyi M, Wardelmann E, Antonescu C, Flanagan A, Dirksen U, Hohenberger P, Baumhoer D, Hartmann W, Vokuhl C, Flucke U, Petersen I, Mechtersheimer G, Capper D, Jones DTW, Fröhling S, Pfister SM and von Deimling A.

    Sarcoma classification by DNA methylation profiling

    NATURE COMMUNICATIONS . 12(1): 498-498. Number of citations: 312

    [doi:10.1038/s41467-020-20603-4]

  • Royer-Pokora B, Busch MA, Tenbusch S, Schmidt M, Beier M, Woods AD, Thiele H and Mora J.

    Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations

    Cancers . 13(1): 1-21. Number of citations: 8

    [doi:10.3390/cancers13010060]

  • Pignata L, Palumbo O, Cerrato F, Acurzio B, de Álava E, Roma J, Gallego S, Mora J, Carella M, Riccio A and Verde G.

    Both Epimutations and Chromosome Aberrations Affect Multiple Imprinted Loci in Aggressive Wilms Tumors

    Cancers . 12(11): . Number of citations: 8

    [doi:10.3390/cancers12113411]

  • Mora J, Castañeda-Heredia A, Flores MA, Santa-María V, Garraus-Oneca M, Gorostegui M, Simao M, Pérez-Jaume S and Mañe S.

    The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies

    FRONTIERS IN PHARMACOLOGY . 11: 575009-575009. Number of citations: 16

    [doi:10.3389/fphar.2020.575009]

  • Martinez-Lage M, Torres-Ruiz R, Puig-Serra P, Moreno-Gaona P, Martin MC, Moya FJ, Quintana-Bustamante O, Garcia-Silva S, Carcaboso AM, Petazzi P, Bueno C, Mora J, Peinado H, Segovia JC, Menendez P and Rodriguez-Perales S.

    In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells

    NATURE COMMUNICATIONS . 11(1): 5060-5060. Number of citations: 68

    [doi:10.1038/s41467-020-18875-x]

  • Sánchez-Molina S, Figuerola-Bou E, Blanco ME, Sanchez-Jimenez M, Táboas-Outón P, Gomez-Gonzalez S, Ballaré C, García-Domínguez DJ, Prada-Varela E, Hontecillas-Prieto L, Carcaboso AM, Tirado ÓM, Hernandez-Muñoz MI, de Álava E, Lavarino C, Di Croce L and Mora J.

    RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

    Science Advances . 6(43): 3058. Number of citations: 27

    [doi:10.1126/sciadv.aba3058]

  • Alcon C, Manzano-Muñoz A, Prada-Varela E, Mora J, Soriano A, Guillén G, Gallego S, Roma J, Samitier J, Villanueva A and Montero J.

    Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance

    CELL DEATH & DISEASE . 11(8): 634-634. Number of citations: 17

    [doi:10.1038/s41419-020-02887-y]

  • Castillo H, Monterrubio C, Pascual-Pastó G, Gomez-Gonzalez S, Garcia-Dominguez DJ, Hontecillas-Prieto L, Resa-Parés C, Burgeño-Sandoval V, Paco-Mercader S, Gene-Olaciregui N, Vilà-Ubach M, Restrepo-Perdomo C, Cuadrado-Vilanova M, Balaguer-Lluna L, Pérez-Jaume S, Castañeda-Heredia A, Santa-María López V, Roldan-Molina M, Suñol M, de Alava E, Mora J, Lavarino C and Carcaboso AM.

    Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution

    JOURNAL OF CONTROLLED RELEASE . 324: 440-449. Number of citations: 7

    [doi:10.1016/j.jconrel.2020.05.032]